戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 degenerative muscle disease of aging humans, sporadic inclusion body myositis.
2 osis, frontotemporal lobar degeneration, and sporadic inclusion body myositis.
3 cts, mtDNA alterations may be accelerated in sporadic inclusion body myositis.
4  the current concepts of the pathogenesis of sporadic inclusion-body myositis.
5 hy of the muscle fibers that are specific to sporadic inclusion-body myositis.
6 so provide new avenues toward the therapy of sporadic inclusion-body myositis.
7 bute only slightly to muscle fiber damage in sporadic inclusion-body myositis.
8 l and important clues to the pathogenesis of sporadic inclusion-body myositis.
9 ments in individual cells from patients with sporadic inclusion body myositis, a late-onset inflammat
10           Muscle biopsies from patients with sporadic inclusion body myositis, a well defined myopath
11  transthyretin Val122Ile allele who has both sporadic inclusion body myositis and cardiac amyloidosis
12 malities in scattered muscle fibers occur in sporadic inclusion body myositis and clinically similar
13 oportion of mtDNA deletions in patients with sporadic inclusion body myositis and control subjects, m
14 ently associated through genetic analyses to sporadic inclusion body myositis and sarcoidosis.
15                                              Sporadic inclusion body myositis and the hereditary incl
16 le for T-cell activation in polymyositis and sporadic inclusion-body myositis and the cause of vacuol
17 agged-red fibers are common in patients with sporadic inclusion body myositis, and multiple [correcti
18 and consequences of genes that predispose to sporadic inclusion-body myositis, and of human muscle fi
19                          In polymyositis and sporadic inclusion-body myositis, antigen-specific and c
20                          In polymyositis and sporadic inclusion body myositis, clonal expansion of CD
21 80 to 90% of the vacuolated muscle fibers of sporadic inclusion body myositis contained well-defined,
22 ory cells that characterize polymyositis and sporadic inclusion-body myositis from the non-specific,
23                                  Interest in sporadic inclusion-body myositis has been enhanced by th
24 e immunostained muscle biopsy specimens from sporadic inclusion body myositis, hereditary inclusion b
25                                Compared with sporadic inclusion body myositis, however, in which the
26 ibody against a 43 kDa muscle autoantigen in sporadic inclusion body myositis (IBM) and demonstrated
27               Historically, the diagnosis of sporadic inclusion body myositis (IBM) has required the
28                  Serum from 70 patients with sporadic inclusion body myositis (IBM) was subjected to
29               To examine new developments in sporadic inclusion body myositis (IBM), including update
30 the pathogenesis, diagnosis and treatment of sporadic inclusion body myositis (IBM).
31 crosis are consistent histologic findings in sporadic inclusion body myositis (IBM).
32                                              Sporadic inclusion-body myositis (IBM) is the most commo
33                                              Sporadic inclusion body myositis is a frequent, acquired
34                        Although the cause of sporadic inclusion body myositis is unknown, GNE myopath
35                                   Typical of sporadic inclusion body myositis muscle biopsies are vac
36 heir consequences, and correlate findings in sporadic inclusion-body myositis muscle biopsies with in
37 nced by the recent identification within the sporadic inclusion-body myositis muscle fibers of severa
38 ry component may only slightly contribute to sporadic inclusion-body myositis muscle-fiber damage.
39 erative inflammatory responses that resemble sporadic inclusion body myositis pathology.
40 is and the cause of vacuolar degeneration in sporadic inclusion-body myositis remain unclear.
41                                 Treatment of sporadic inclusion-body myositis remains a challenge.
42                                              Sporadic inclusion body myositis (s-IBM) is a chronic in
43 lated tau, are the characteristic feature of sporadic inclusion body myositis (s-IBM) muscle biopsies
44 n immunodeficiency virus infection (HIV-PM), sporadic inclusion body myositis (s-IBM), dermatomyositi
45 t these patients have a disease identical to sporadic inclusion body myositis (s-IBM).
46                                              Sporadic inclusion-body myositis (s-IBM) and hereditary
47 lated to seeking the pathogenic mechanism of sporadic inclusion-body myositis (s-IBM) and hereditary
48                                              Sporadic inclusion-body myositis (s-IBM) is the most com
49                                              Sporadic inclusion-body myositis (s-IBM) is the most com
50                  The hallmark pathologies of sporadic inclusion-body myositis (s-IBM) muscle fibers a
51 ultiprotein-aggregates are characteristic of sporadic inclusion-body myositis (s-IBM) muscle fibers.
52       Because in the muscle of patients with sporadic inclusion body myositis (sIBM) clonally expande
53                                              Sporadic inclusion body myositis (sIBM) is a poorly unde
54                                              Sporadic inclusion body myositis (sIBM) is an inflammato
55                                              Sporadic Inclusion Body Myositis (sIBM) is the most comm
56 regate in the muscle fibers of patients with sporadic inclusion body myositis (sIBM) is unknown.
57                                              Sporadic inclusion body myositis (sIBM) pathogenesis is
58 uding the TAR DNA binding protein TDP-43, in sporadic inclusion body myositis (sIBM) sarcoplasm are i
59                                              Sporadic inclusion body myositis (sIBM), a common adult-
60 allmarks of the skeletal muscle pathology in sporadic inclusion body myositis (sIBM), have remained e
61 yositis (PM), Necrotizing Myositis (NM), and sporadic Inclusion Body Myositis (sIBM).
62 regates, in the pathogenesis of familial and sporadic inclusion body myositis (sIBM).
63                                              Sporadic inclusion-body myositis (sIBM) is the most comm
64                                           In sporadic inclusion-body myositis the inflammatory cells
65 rder associated with aging and is related to sporadic inclusion body myositis, the most common acquir
66           In conceptualizing a treatment for sporadic inclusion-body myositis, the accumulations of a
67                                              Sporadic inclusion-body myositis, the most common muscle
68                                              Sporadic inclusion-body myositis, the most common muscle
69                  We studied 56 patients with sporadic inclusion body myositis, using a combination of

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。